The Pharma Letter

The Pharma Letter (or TPL), is an English pharmaceutical, generics and biotechnology news and analysis service.[1]

Description

Coverage includes:[1]

  • Company news. Financial reports, marketing developments, trends and strategies, corporate development, company profiles, legal influences, Research and Development trends, mergers and acquisitions activity, sales performance, stock market analyses and personnel appointments.
  • Product news. Drug submissions, approvals and rejections, licensing arrangements, clinical trial developments and results, product development and new product introductions.
  • European, USA, and World news. Regulatory developments, FDA/EMEA news, market legislation, pharma market movements, reviews of current and proposed legislation and regulation, conference details, and write-ups.

Barbara Obstoj is the Managing Editor, which in 2009 acquired the archives of The Pharma Marketletter, a publication Barbara owned since 1991 and prior to that edited when it was part of IMS Health.[1] She was also the founding editor of Scrip World Pharmaceutical News from 1972 to 1976.[1]

gollark: Maybe you have a firewall set up.
gollark: Oh, it mentions that as another thing. Stupid slowmode.
gollark: It does? Huh.
gollark: As far as I know most physics runs on the client, but it also sets NBT things, so who knows.
gollark: I've skimmed the code, and it might or might not be doing servery things. I can't tell.

References
  1. "About Us". thepharmaletter.com. Retrieved 18 March 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.